Highly Atherogenic Lipid Particles After Fertility Treatment Denote Preeclampsia in Obese Women

Written By: user

IJCP Editorial Team

Published On: 16 Oct, 2023 1:08 PM | Updated On: 16 Oct, 2023 2:44 PM

Highly Atherogenic Lipid Particles After Fertility Treatment Denote Preeclampsia in Obese Women

A recent study aimed to investigate the connection between atherogenic dyslipidemia and preeclampsia development during pregnancy – which could subsequently increase the risk of cardiovascular disease. This research was part of a larger clinical trial called "Improving Reproductive Fitness Through Pretreatment with Lifestyle Modification in Obese Women with Unexplained Infertility" (FIT-PLESE), focusing on obese women with unexplained infertility.

The study involved 279 participants, of whom 80 successfully delivered. Blood samples were collected at various points, including before and after lifestyle interventions and during pregnancy.

The findings showed that women who developed preeclampsia had unfavorable cholesterol/high-density lipoprotein (HDL) ratios, higher triglyceride levels, and worse triglyceride/HDL ratios, even after adjusting for body mass index (BMI). Additionally, certain subclasses of very small, low-density lipoprotein (LDL) particles, known for their atherogenic properties, were higher in women with preeclampsia during pregnancy.

In inference, it was stated that the role of these specific LDL particles in the development of preeclampsia requires further investigation.

Source: Wild RA, Edwards RK, Zhao D, Hansen KR, Kim AS, Wrenn DS. Reproductive Sciences. 2023 Feb 22:1-8.

IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.